| Trial Identifier: | D5495C00006 |
| Sponsor: | AstraZeneca |
| Collaborator: |
PAREXEL Early Phase Clinical Unit
|
| NCTID:: | NCT03836599 |
| Start Date: | January 2019 |
| Primary Completion Date: | April 2019 |
| Study Completion Date: | April 2019 |
| Condition: | Chronic Kidney Diseases |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Translation | |
| Japanese Translation | |
| Korean Translation | |
| Chinese Translation | |
| Traditional Chinese Translation |
| Country | Location |
|---|---|
| United States of America, CA | Glendale, CA, United States of America, 91206 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2024 Pharma Intelligence UK Limited (Citeline), a Norstella company